Major study on Duchenne muscular dystrophy gains support

Harvard stem-cell research receives support from Sarepta Therapeutics for work on Duchenne muscular dystrophy.

Caroline Perry • harvard
Jan. 9, 2020 ~6 min

Tags:  science-technology  stem-cells  office-of-technology-development  amy-wagers  caroline-perry  duchenne-muscular-dystrophy  sarepta-therapeutics

Page 1 of 1